Rossmax International Ltd. (TPEX:4121)
15.05
-0.10 (-0.66%)
Jan 22, 2026, 1:30 PM CST
Rossmax International Revenue
Rossmax International had revenue of 941.06M TWD in the quarter ending September 30, 2025, a decrease of -3.36%. This brings the company's revenue in the last twelve months to 3.82B, down -0.62% year-over-year. In the year 2024, Rossmax International had annual revenue of 3.85B with 1.11% growth.
Revenue (ttm)
3.82B
Revenue Growth
-0.62%
P/S Ratio
0.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.85B | 42.10M | 1.11% |
| Dec 31, 2023 | 3.81B | -535.69M | -12.33% |
| Dec 31, 2022 | 4.34B | 397.05M | 10.06% |
| Dec 31, 2021 | 3.95B | 268.93M | 7.31% |
| Dec 31, 2020 | 3.68B | 585.02M | 18.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cowealth Medical Holding | 3.41B |
| Wellell | 2.39B |
| OK Biotech | 1.64B |
| AViTA | 896.85M |
| Bioptik Technology Incorporation | 829.18M |
| Radiant Innovation | 413.06M |
| Wiltrom | 338.37M |
| S&S Healthcare Holding | 205.64M |